Darifenacin Hydrobromide Darifenacin HBr CAS 133099-07-7 Assay ≥99.0% API Factory High Quality
Samar da Mai ƙira tare da Tsaftataccen Tsafta da Tsayayyen inganci
Sunan Sinadari: Darifenacin Hydrobromide
Saukewa: 133099-07
Darifenacin hydrobromide wani zaɓi ne na M3 muscarinic antagonist mai karɓa wanda aka yi amfani da shi don magance rashin iyawar fitsari da ciwon mafitsara.
API High Quality, Kasuwancin Kasuwanci
Sunan Sinadari | Darifenacin Hydrobromide |
Makamantu | Darifenacin HBr;Birtaniya-88525;Enablex |
Lambar CAS | 133099-07-7 |
Lambar CAT | RF-API94 |
Matsayin Hannun jari | A Hannun jari, Ma'aunin Samfuran Har zuwa Daruruwan Kilogram |
Tsarin kwayoyin halitta | C28H30N2O2.HBr |
Nauyin Kwayoyin Halitta | 507.46 |
Matsayin narkewa | 228.0 ~ 230.0 ℃ |
Solubility | DMSO: mai narkewa 20mg/ml, bayyananne |
Ajiya Zazzabi | Adana Dogon lokaci a -20 ℃ |
Alamar | Ruifu Chemical |
Abu | Ƙayyadaddun bayanai |
Bayyanar | Farin Crystalline Foda |
Solubility | Yana Soluble a cikin Methanol, Dan Soluble a Ruwa da Aiki A zahiri a Chloroform |
Gano IR | Bakan samfurin yayi daidai da na ma'aunin tunani |
Bayanin HPLC | Lokacin riƙewa na babban kololuwar samfurin samfurin ya dace da na daidaitaccen bayani |
Abubuwa masu alaƙa | |
Max.Tsaftace Guda Daya | ≤0.50% |
Jimlar ƙazanta | ≤1.0% |
Isomer na gani | ≤0.50% |
Ragowar Magani | |
Ethyl acetate | ≤0.50% |
Ethanol | ≤0.50% |
Methanol | ≤0.30% |
Acetone | ≤0.50% |
1-Butanol | ≤0.50% |
Asara akan bushewa | ≤1.0% (Bushe a 105 ℃ a cikin na'urar busar da iska ta lantarki har sai nauyi mai tsayi) |
Ragowa akan Ignition | ≤0.10% |
Karfe masu nauyi | ≤20ppm |
Assay | ≥99.0% (a busasshiyar tushe) |
Rayuwar Rayuwa | Watanni 24 |
Matsayin Gwaji | Matsayin Kasuwanci |
Amfani | API, Mafitsara mai aiki |
Kunshin: Bottle, Aluminum tsare jakar, Kwali drum, 25kg / Drum, ko bisa ga abokin ciniki ta bukata.
Yanayin Ajiya:Ajiye a cikin kwantena da aka rufe a wuri mai sanyi da bushe;Kare daga haske, danshi da kamuwa da kwari.
Darifenacin Hydrobromide, Darifenacin HBr (CAS 133099-07-7), mai aiki da baki, sau ɗaya a rana zaɓin mai karɓar mai karɓar mai karɓa na M3, an ƙaddamar da shi don maganin mafitsara mai aiki a cikin marasa lafiya tare da alamun rashin ƙarfi na fitsari, gaggawa da mita.Magungunan da aka zaɓa yana hana mai karɓar M3 a cikin tsoka mai lalacewa yayin da yake adana masu karɓa na M1 da M2 waɗanda aka yi imani da cewa suna da hannu a cikin tsarin juyayi na tsakiya da aikin zuciya da jijiyoyin jini bi da bi.Pfizer ne ya samar da ginin asali kuma an ba shi lasisi zuwa Novartis da Bayer.